Literature DB >> 31107541

The future burden of kidney and bladder cancers preventable by behavior modification in Australia: A pooled cohort study.

Maarit A Laaksonen1, Robert J MacInnis2,3, Karen Canfell4,5,6, Graham G Giles2,3, Peter Hull1, Jonathan E Shaw7, Robert G Cumming5,8, Tiffany K Gill9, Emily Banks10, Paul Mitchell11, Julie E Byles12, Dianna J Magliano13, Vasant Hirani5,14, David Connah15, Claire M Vajdic1.   

Abstract

Substantial changes in the prevalence of the principal kidney and bladder cancer risk factors, smoking (both cancers) and body fatness (kidney cancer), have occurred but the contemporary cancer burden attributable to these factors has not been evaluated. We quantified the kidney and bladder cancer burden attributable to individual and joint exposures and assessed whether these burdens differ between population subgroups. We linked pooled data from seven Australian cohorts (N = 367,058) to national cancer and death registries and estimated the strength of the associations between exposures and cancer using adjusted proportional hazards models. We estimated exposure prevalence from representative contemporaneous health surveys. We combined these estimates to calculate population attributable fractions (PAFs) with 95% confidence intervals (CIs), accounting for competing risk of death, and compared PAFs for population subgroups. During the first 10-year follow-up, 550 kidney and 530 bladder cancers were diagnosed and over 21,000 people died from any cause. Current levels of overweight and obesity explain 28.8% (CI = 17.3-38.7%), current or past smoking 15.5% (CI = 6.0-24.1%) and these exposures jointly 39.6% (CI = 27.5-49.7%) of the kidney cancer burden. Current or past smoking explains 44.4% (CI = 35.4-52.1%) of the bladder cancer burden, with 24.4% attributable to current smoking. Ever smoking explains more than half (53.4%) of the bladder cancer burden in men, and the burden potentially preventable by quitting smoking is highest in men (30.4%), those aged <65 years (28.0%) and those consuming >2 standard alcoholic drinks/day (41.2%). In conclusion, large fractions of kidney and bladder cancers in Australia are preventable by behavior change.
© 2019 UICC.

Entities:  

Keywords:  bladder cancer; kidney cancer; population attributable fraction; preventable burden; risk factors

Mesh:

Year:  2019        PMID: 31107541     DOI: 10.1002/ijc.32420

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  5 in total

1.  A four-miRNA signature in serum as a biomarker for bladder cancer diagnosis.

Authors:  Rongkang Li; Xuan Chen; Xinji Li; Guocheng Huang; Chong Lu; Zhenyu Wen; Zebo Chen; Yongqing Lai
Journal:  Am J Transl Res       Date:  2022-07-15       Impact factor: 3.940

2.  A global, regional, and national survey on burden and Quality of Care Index (QCI) of bladder cancer: The global burden of disease study 1990-2019.

Authors:  Amirali Karimi; Parnian Shobeiri; Sina Azadnajafabad; Masoud Masinaei; Negar Rezaei; Ali Ghanbari; Nazila Rezaei; Mahtab Rouhifard; Sarvenaz Shahin; Mohammad-Mahdi Rashidi; Mohammad Keykhaei; Ameneh Kazemi; Erfan Amini; Bagher Larijani; Farshad Farzadfar
Journal:  PLoS One       Date:  2022-10-20       Impact factor: 3.752

Review 3.  Cigarette smoking and risk of bladder cancer: a dose-response meta-analysis.

Authors:  Xiaohu Zhao; Yuanli Wang; Chaozhao Liang
Journal:  Int Urol Nephrol       Date:  2022-03-25       Impact factor: 2.370

4.  The blood metabolome of incident kidney cancer: A case-control study nested within the MetKid consortium.

Authors:  Florence Guida; Vanessa Y Tan; Laura J Corbin; Karl Smith-Byrne; Karine Alcala; Claudia Langenberg; Isobel D Stewart; Adam S Butterworth; Praveen Surendran; David Achaintre; Jerzy Adamski; Pilar Amiano; Manuela M Bergmann; Caroline J Bull; Christina C Dahm; Audrey Gicquiau; Graham G Giles; Marc J Gunter; Toomas Haller; Arnulf Langhammer; Tricia L Larose; Börje Ljungberg; Andres Metspalu; Roger L Milne; David C Muller; Therese H Nøst; Elin Pettersen Sørgjerd; Cornelia Prehn; Elio Riboli; Sabina Rinaldi; Joseph A Rothwell; Augustin Scalbert; Julie A Schmidt; Gianluca Severi; Sabina Sieri; Roel Vermeulen; Emma E Vincent; Melanie Waldenberger; Nicholas J Timpson; Mattias Johansson
Journal:  PLoS Med       Date:  2021-09-20       Impact factor: 11.069

5.  Global, regional, and national burdens of bladder cancer in 2017: estimates from the 2017 global burden of disease study.

Authors:  Hairong He; Hongjun Xie; Yule Chen; Chengzhuo Li; Didi Han; Fengshuo Xu; Jun Lyu
Journal:  BMC Public Health       Date:  2020-11-11       Impact factor: 3.295

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.